GRIB has a wide experience in the participation and coordination of research projects in the field of Bioinformatics, funded by the European Commission and other research funding agencies. It also has a long tradition of collaboration with the pharmaceutical and biotechnological industry in the framework of R&D projects and providing services, especially in the development of computational methods for drug discovery and toxicity assesment. Some of these companies are listed below:

• AstraZeneca AB (SE)
• Boehringer Ingelheim International GmbH (DE)
• Glaxosmithkline Research and Development LTD (UK)
• Eli Lilly and Company Ltd (UK)
• Sanofi Aventis GmbH (DE)
• F. Hoffmann - La Roche AG (CH)
• Institut de Recherches Internationales Servier (FR)
• Lhasa Limited (UK)
• Molecular Networks GmbH (DE)
• Novartis Pharma AG (CH)
• Janssen Pharmaceutica NV (BE)

Some of the Project Consortiums with the participation of GRIB

• TransQST project consortium 
• eTRANSAFE project consortium 
• EUTOXRISK project consortium
• Compbiomed project consortium